Hepatitis C primary prevention: Difference between revisions
m Bot: Removing from Primary care |
|||
| Line 14: | Line 14: | ||
* Test donated [[blood]] | * Test donated [[blood]] | ||
* Improve access to safe blood | * Improve access to safe blood | ||
* Health care, emergency medical, and public safety workers after sticks with [[needles]] or sharps or [[mucosa|mucosal]] exposure to [[HCV]]-infected [[blood]] should be screened. | |||
{{fontcolor|red|'''''Recommendations for IV drug users'''''}}<ref name="who">World Health Organization (WHO) 2014. Guidelines for the screening, care and treatment of persons with hepatitis C infection.http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/. Accessed online on July 24,2014.</ref> | {{fontcolor|red|'''''Recommendations for IV drug users'''''}}<ref name="who">World Health Organization (WHO) 2014. Guidelines for the screening, care and treatment of persons with hepatitis C infection.http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/. Accessed online on July 24,2014.</ref> | ||
* IV drug users should be offered the rapid [[hepatitis B]] vaccine regimen | * IV drug users should be offered the rapid [[hepatitis B]] [[vaccine]] regimen | ||
* Implement sterile needle and syringe programmes | * Implement sterile needle and syringe programmes | ||
* Offer peer interventions to IV drug users | * Offer peer interventions to IV drug users | ||
| Line 24: | Line 25: | ||
* Promote correct and consistent condom use | * Promote correct and consistent condom use | ||
* Routine [[screening]] of sex workers in high-prevalence settings | * Routine [[screening]] of sex workers in high-prevalence settings | ||
* Eliminate discrimination and gender violence | * Eliminate discrimination and gender violence. | ||
*Annual [[HCV]] testing for PWID and [[HIV]]-seropositive [[men]] who have unprotected sexual intercourse with men. Periodic testing should be offered to other individuals with ongoing [[risk factors]] for exposure to [[HCV]]. | |||
{{fontcolor|red|'''''Recommendations for pregnant females and children born to the infected'''''}} | |||
One-time screening of [[pregnant]] females is recommended unless [[risk factors]] require additional testing. | |||
* Children born to [[HCV]]-infected [[females]]. | |||
*Screening Recommendations From the AASLD/IDSA and the CDC include: | |||
*''General'': | |||
One-time, routine, opt-out [[HCV]] testing is recommended for all individuals aged 18 years or [[old]]er. For indiividuals younger than 18 [[years]], [[HCV]] testing should be performed in the setting of exposures, and conditions and behaviors where increased risk of [[HCV]] is anticipated. | |||
Risk Behaviors | |||
Injection drug use (current or ever, including those who have injected once) | |||
{{fontcolor|red|'''''Recommended screening for individuals with risk exposures'''''}} | |||
*Individuals who have ever received long-term [[hemodialysis]], had [[percutaneous]]/[[parenteral]] exposure in unregulated setting. | |||
* Screening for recipients of transfusions or organ [[transplant]]s, including individuals who got notified having received [[blood]] from a later [[diagnosed]] [[HCV]] positive donor. Individuals who received a [[blood]] [[transfusion]] transfusion or an organ transplant before July 1992, received [[clotting factor]] concentrates produced before 1987, ever incarcerated. | |||
*Individuals with [[HIV]] infection, plan on initiating preexposure [[prophylaxis]] for [[HIV]], with unexplained [[chronic liver disease|CLD]], [[chronic hepatitis]], and solid organ donors ([[alive]] or [[dead]]) | |||
==References== | ==References== | ||
Revision as of 19:12, 19 May 2021
|
Hepatitis C |
|
Diagnosis |
|
Treatment |
|
Hepatitis C primary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatitis C primary prevention |
|
Risk calculators and risk factors for Hepatitis C primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In the absence of available vaccine, primary prevention of HCV depends mostly on avoiding exposure to the virus.
Primary Prevention
Unlike hepatitis A and hepatitis B, there are currently no readily available vaccines for hepatitis C. Primary prevention of HCV relies mostly on measures that decrease exposure to the virus. Recommendations are based on the routes of transmission, and populations at risk.
Recommendations for healthcare workers[1]
- Proper hand hygiene and use of gloves when indicated
- Safe handling and disposal of sharps and contaminated waste
- Train healthcare personnel
- Test donated blood
- Improve access to safe blood
- Health care, emergency medical, and public safety workers after sticks with needles or sharps or mucosal exposure to HCV-infected blood should be screened.
Recommendations for IV drug users[1]
- IV drug users should be offered the rapid hepatitis B vaccine regimen
- Implement sterile needle and syringe programmes
- Offer peer interventions to IV drug users
- Offer opioid substitution therapy to treat opioid dependence to decrease risky behavior
Recommendations for sexual transmission of HCV[1]
- Promote correct and consistent condom use
- Routine screening of sex workers in high-prevalence settings
- Eliminate discrimination and gender violence.
- Annual HCV testing for PWID and HIV-seropositive men who have unprotected sexual intercourse with men. Periodic testing should be offered to other individuals with ongoing risk factors for exposure to HCV.
Recommendations for pregnant females and children born to the infected One-time screening of pregnant females is recommended unless risk factors require additional testing.
- Screening Recommendations From the AASLD/IDSA and the CDC include:
- General:
One-time, routine, opt-out HCV testing is recommended for all individuals aged 18 years or older. For indiividuals younger than 18 years, HCV testing should be performed in the setting of exposures, and conditions and behaviors where increased risk of HCV is anticipated.
Risk Behaviors
Injection drug use (current or ever, including those who have injected once)
Recommended screening for individuals with risk exposures
- Individuals who have ever received long-term hemodialysis, had percutaneous/parenteral exposure in unregulated setting.
- Screening for recipients of transfusions or organ transplants, including individuals who got notified having received blood from a later diagnosed HCV positive donor. Individuals who received a blood transfusion transfusion or an organ transplant before July 1992, received clotting factor concentrates produced before 1987, ever incarcerated.
- Individuals with HIV infection, plan on initiating preexposure prophylaxis for HIV, with unexplained CLD, chronic hepatitis, and solid organ donors (alive or dead)
References
- ↑ 1.0 1.1 1.2 World Health Organization (WHO) 2014. Guidelines for the screening, care and treatment of persons with hepatitis C infection.http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/. Accessed online on July 24,2014.